Debashish Dey M.D.

Debashish Dey MD, PhD, MPH has an extensive work history in various pharmaceutical companies. Debashish is currently serving as the Vice President and Head of Drug Safety & Pharmacovigilance at Intellia Therapeutics, Inc. Prior to this, they held the position of Vice President and Head of Global Pharmacovigilance & Drug Safety at Acceleron Pharma. Debashish also worked as the Vice President and Head of Global Patient Safety at AveXis (Novartis Gene Therapy) and as the Head of Hematology, Global Drug Safety at Shire. Additionally, they have experience working at Eli Lilly and Company, Novartis, Sahlgrenska Academy at the University of Gothenburg, and AstraZeneca in various research and advisory roles related to patient safety and epidemiology.

Debashish Dey MD, PhD, MPH obtained their MBBS (MD) degree in Medicine from Dhaka Medical College between 1986 and 1993. Debashish then pursued a MPH in Epidemiology at Umeå University from 1997 to 1998. Following this, they completed their PhD/MD in Geriatric Medicine at the University of Gothenburg from 1998 to 2002. Debashish furthered their education by earning a Masters in Project Management from The George Washington University School of Business from 2005 to 2009.